#begin document (nw/p2.5_c2e/00/p2.5_c2e_0016); part 000
nw/p2.5_c2e/00/p2.5_c2e_0016   0   0    Chinanews.com   NNP   (TOP(FRAG(NP*)  -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   1                ,     ,               *   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   2         December   NNP            (NP*   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   3              13     CD               *)  -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   4                .     .              *))  -   -   -   -   *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0        Taiwan     NNP  (TOP(S(NP(NP*          -    -   -   -   *       (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1            's     POS              *)         -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2             "      ``              *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3        Health     NNP              *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4    Department     NNP              *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5             "      ''              *)         -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6         today      NN        (NP(NP*)         -    -   -   -   *   (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7        -LRB-   -LRB-               *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8          13th      NN              *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9        -RRB-   -RRB-               *)         -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10     announced     VBD           (VP*    announce  01   1   -   *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11           its    PRP$           (NP*          -    -   -   -   *       (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12             "      ``              *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   13         2003       CD              *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   14        Cancer     NNP          (NML*          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   15      Registry     NNP              *)         -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   16        Report     NNP              *          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   17             "      ''             *))         -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   18             .       .             *))         -    -   -   -   *            *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0         Apart    RB    (TOP(S(ADVP*    -    -   -   -   *               *   (ARGM-ADV*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1          from    IN            (PP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2     carcinoma    NN      (NP(NP(NP*)   -    -   -   -   *      (ARGM-LOC*            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3            in    IN            (PP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4          situ    NN          (NP*)))   -    -   -   -   *               *)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5         where   WRB   (SBAR(WHADVP*)   -    -   -   -   *    (R-ARGM-LOC*)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6           the    DT       (S(NP(NP*    -    -   -   -   *          (ARG1*            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7          rate    NN               *)   -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8            of    IN            (PP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9    successful    JJ            (NP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10     treatment    NN             *)))   -    -   -   -   *               *)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11            is   VBZ            (VP*    be  01   1   -   *             (V*)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12        almost    RB         (NP(QP*    -    -   -   -   *          (ARG2*            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   13          100     CD               *)   -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   14             %    NN         *)))))))   -    -   -   -   *               *)           *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   15             ,     ,               *    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   16           the    DT         (NP(NP*    -    -   -   -   *               *       (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   17    occurrence    NN               *    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   18          rate    NN               *)   -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   19            of    IN            (PP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   20        cancer    NN           (NP*))   -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   21            on    IN            (PP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   22           the    DT            (NP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   23        island    NN             *)))   -    -   -   -   *               *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   24            is   VBZ            (VP*    be  01   2   -   *               *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   25       250.77     CD         (NP(NP*    -    -   -   -   *               *       (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   26        people   NNS               *)   -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   27           per    IN            (PP*    -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   28      100,000     CD         (NP*))))   -    -   -   -   *               *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   29             .     .              *))   -    -   -   -   *               *            *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0         On    IN  (TOP(S(PP*     -    -   -   -   *   (ARGM-PRD*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1    average    JJ     (ADJP*))    -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2          ,     ,           *     -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3          a    DT        (NP*     -    -   -   -   *       (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4        new    JJ           *     -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5     cancer    NN           *     -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6    patient    NN           *)    -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7         is   VBZ        (VP*     -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8      added   VBN        (VP*    add  02   -   -   *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9      every    DT        (NP*     -    -   -   -   *   (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10       8.4     CD           *     -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11    minutes   NNS         *)))    -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12          .     .          *))    -    -   -   -   *            *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0            Of    IN  (TOP(S(PP*    -    -   -   -   *   (ARGM-DIS*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1         these    DT       (NP*))   -    -   -   -   *            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2             ,     ,           *    -    -   -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3           the    DT     (NP(NP*    -    -   -   -   *       (ARG1*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4       highest   JJS           *    -    -   -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5    occurrence    NN           *)   -    -   -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6           for    IN        (PP*    -    -   -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7           men   NNS      (NP*)))   -    -   -   -   *            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8            is   VBZ        (VP*    be  01   2   -   *          (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9         liver    JJ        (NP*    -    -   -   -   *       (ARG2*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10        cancer    NN           *)   -    -   -   -   *            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11             ,     ,           *    -    -   -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12         while    IN      (SBAR*    -    -   -   -   *   (ARGM-ADV*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   13           for    IN   (S(NP(PP*    -    -   -   -   *            *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   14         women   NNS      (NP*)))   -    -   -   -   *            *        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   15            is   VBZ        (VP*    be  01   2   -   *            *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   16        breast    NN        (NP*    -    -   -   -   *            *   (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   17        cancer    NN       *)))))   -    -   -   -   *            *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   18             .     .          *))   -    -   -   -   *            *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0      According   VBG   (TOP(S(PP*        -    -   -   -   *   (ARGM-ADV*             *   (ARGM-ADV*            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1             to    IN         (PP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2              a    DT         (NP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3              "    ``            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4        Central   NNP        (NML*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5           News   NNP            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6         Agency   NNP            *)       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7              "    ''            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8         report    NN          *)))       -    -   -   -   *            *)            *            *)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9              ,     ,            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10              "    ``            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11         Health   NNP         (NP*        -    -   -   -   *       (ARG0*             *       (ARG0*            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12     Department   NNP            *)       -    -   -   -   *            *)            *            *)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   13              "    ''            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   14        studied   VBD      (VP(VP*     study  01   1   -   *          (V*)            *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   15            the    DT      (NP(NP*        -    -   -   -   *       (ARG1*             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   16          newly    RB       (ADJP*        -    -   -   -   *            *    (ARGM-TMP*)           *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   17       detected   VBN            *)   detect  01   -   -   *            *           (V*)           *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   18     individual    JJ            *        -    -   -   -   *            *        (ARG1*            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   19         cancer    NN            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   20          cases   NNS            *)       -    -   -   -   *            *             *)           *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   21            for    IN         (PP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   22            the    DT   (NP(NP(NP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   23         entire    JJ            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   24         island    NN            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   25             's   POS            *)       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   26           212     CD            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   27      hospitals   NNS            *)       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   28           with    IN         (PP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   29            the    DT      (NP(NP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   30          scale    NN            *)       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   31             of    IN         (PP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   32           more   JJR      (NP(QP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   33           than    IN            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   34            50     CD            *)       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   35           beds   NNS     *))))))))       -    -   -   -   *            *)            *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   36            and    CC            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   37       revealed   VBD         (VP*    reveal  01   2   -   *            *             *          (V*)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   38           that    IN       (SBAR*        -    -   -   -   *            *             *       (ARG1*            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   39             an    DT    (S(NP(NP*        -    -   -   -   *            *             *            *       (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   40    approximate    JJ            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   41     occurrence    NN            *        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   42           rate    NN            *)       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   43             of    IN         (PP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   44         cancer    NN        (NP*))       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   45             on    IN         (PP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   46            the    DT         (NP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   47         island    NN          *)))       -    -   -   -   *            *             *            *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   48             is   VBZ         (VP*        be  01   2   -   *            *             *            *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   49        250.77     CD      (NP(NP*        -    -   -   -   *            *             *            *       (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   50         people   NNS            *)       -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   51            per    IN         (PP*        -    -   -   -   *            *             *            *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   52       100,000     CD       (NP*)))       -    -   -   -   *            *             *            *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   53             in    IN         (PP*        -    -   -   -   *            *             *            *   (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   54          2003     CD   (NP*)))))))       -    -   -   -   *            *             *            *)           *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   55              .     .           *))       -    -   -   -   *            *             *            *            *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0           And    CC       (TOP(S*    -    -   -   -   *    (ARGM-DIS*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1           the    DT          (NP*    -    -   -   -   *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2          most   RBS        (ADJP*    -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3      frequent    JJ             *)   -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4    occurrence    NN             *)   -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5            is   VBZ          (VP*    be  01   1   -   *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6            at    IN          (PP*    -    -   -   -   *        (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7           age    NN       (NP(NP*)   -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8            of    IN          (PP*    -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9           65     CD    (NP(NP(NP*)   -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10           for    IN          (PP*    -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11           men   NNS        (NP*)))   -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12           and    CC             *    -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   13           60     CD       (NP(NP*)   -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   14           for    IN          (PP*    -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   15         women   NNS   (NP*))))))))   -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   16             .     .            *))   -    -   -   -   *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0                Of    IN  (TOP(S(PP*           -    -   -   -   *   (ARGM-DIS*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1             these    DT       (NP*))          -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3               the    DT     (NP(NP*           -    -   -   -   *       (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4               ten    CD           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5              most   RBS      (ADJP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6          frequent    JJ           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7       occurrences   NNS           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8                of    IN        (PP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9            cancer    NN       (NP*))          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10                in    IN        (PP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11               men   NNS      (NP*)))          -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12               are   VBP        (VP*           be  01   1   -   *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   13                in    IN        (PP*           -    -   -   -   *   (ARGM-ADV*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   14               the    DT        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   15         following    NN           *    following   -   3   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   16             order    NN          *))          -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   17                 :     :           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   18             liver    NN     (NP(NP*           -    -   -   -   *       (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   19            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   20                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   21              lung    NN        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   22            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   23                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   24             colon    NN    (NP(UCP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   25               and    CC           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   26            rectal    JJ           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   27            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   28                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   29              oral    JJ        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   30            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   31                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   32           stomach    NN        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   33            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   34                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   35          prostate    NN        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   36            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   37                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   38           bladder    NN        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   39            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   40                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   41        esophageal    JJ        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   42            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   43                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   44    nasopharyngeal    JJ        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   45            cancer    NN           *)          -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   46                 ,     ,           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   47               and    CC           *           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   48              skin    NN        (NP*           -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   49            cancer    NN         *)))          -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   50                 .     .          *))          -    -   -   -   *            *   -

nw/p2.5_c2e/00/p2.5_c2e_0016   0    0            For    IN  (TOP(S(PP*    -    -   -   -   *   (ARGM-ADV*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    1          women   NNS       (NP*))   -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    2              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    3            the    DT     (NP(NP*    -    -   -   -   *       (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    4            ten    CD           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    5           most   RBS      (ADJP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    6         common    JJ           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    7        cancers   NNS           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    8             in    IN        (PP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0    9          order    NN     (NP(NP*)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   10             of    IN        (PP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   11    occurrences   NNS    (NP*)))))   -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   12            are   VBP        (VP*    be  01   2   -   *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   13              :     :           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   14         breast    NN     (NP(NP*    -    -   -   -   *       (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   15         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   16              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   17          colon    NN    (NP(UCP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   18            and    CC           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   19         rectal    JJ           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   20         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   21              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   22          liver    NN        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   23         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   24              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   25           lung    NN        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   26         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   27              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   28        uterine    JJ        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   29       cervical    JJ           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   30         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   31              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   32        stomach    NN        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   33         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   34              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   35        thyroid    NN        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   36         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   37              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   38        ovarian    JJ        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   39         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   40              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   41         uterus    NN        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   42         cancer    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   43              ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   44            and    CC           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   45           skin    NN        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   46         cancer    NN         *)))   -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0016   0   47              .     .          *))   -    -   -   -   *            *   -

#end document
